Drug class linked to worse outcomes after transplant Medical Xpress Tamara Isakova, M.D., from the University of Miami, and colleagues compared clinical outcomes in 139,370 kidney transplant patients in the United States receiving mTOR inhibitors or calcineurin inhibitors (3,237 receiving mTOR inhibitors; 125,623 ... |
